Chen, Baoan

Cheng, Hongyan

Cheng, Lu

Feng, Jifeng

Lu, Zuhong

Sun, Ning

Sun, Xinchen

English

PubMed

Springer - Publisher Connector

MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer

A family of drug transporters: the multidrug resistance-associated proteins.

A human canalicular multispeciWc organic anion transporter (cMOAT) gene is overexpressed in cisplatin resistant human cancer cell lines with decreased drug accumulation.

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.

Alexandrie AK et al (2001) Metabolic gene polymorphism frequencies in control populations.

An immunohistochemical study of pi class glutathione Stransferase expression in normal human tissue.

An improved gel-based DNA microarray method for detecting single nucleotide mismatch.

Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required.

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.

Belani CP et al (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

BisulWte modiWcation of immobilized DNAs for methylation detection.

Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev Mol Diagn 6:319–331

Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways.

Dazert E et al (2007) InXuence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.

Expression and function of eZux drug transporters in the intestine.

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.

Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population.

Glutathione S transferase-pi gene expression and platinum drug exposure in human lung cancer.

Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.

Glutathione-S transferase family of enzymes.

Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution.

Immobilization of acrylamide-modiWed oligonucleotides by co-polymerization.

Immunohistochemical localization of glutathione S-transferases in human lung cancer.

Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.

Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.

Inhibition of Mrp2-and Ycf1p-mediated transport by reducing agents: evidence for GSH transport on rat MRP2.

Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions.

Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 53:205–213

Molecular epidemiology of the human glutathione S transferase genotypes GSTM1 and GSTT1 in cancer susceptibility.

Molecular mechanisms of resistance and toxicity associated with platinating agents.

Nomenclature for mammalian soluble glutathione transferases.

Overexpression of cMOAT(MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin.

Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells.

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia.

Relling MV

Rollinson S et al (2001) Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy induced leukaemia.

Single nucleotide polymorphisms in MRP2 gene and their signiWcance on chemosensitivity of advanced ovarian cancer.

Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition.

Soyama A et al (2002) Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 59-untranslated region and exon

The Big Lung Trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC)— Preliminary results in the supportive care setting.

The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate speciWcity and regulation.

The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.

The role of p53 in treatment responses of lung cancer.

The treatment of advanced nonsmall cell lung cancer.

The world health report 2002: reducing risks, promoting healthy life. Educ Health

Twenty-two years of phase III trials for patients with advanced non-small cell lung cancer: sobering results.

Variable expression of MRP2 (ABCC2) in human placenta: inXuence of gestational age and cellular diVerentiation. Drug Metab Dispos 33:896–904

Yoo YK et al (2007) Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.

Zheng WL et al (2008) Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.

file:///data/core-remote/dit/data/Springer-OA/pdf/5a8/aHR0cDovL2xpbmsuc3ByaW5nZXIuY29tLzEwLjEwMDcvczAwMjgwLTAwOS0xMDQ2LTEucGRm.pdf

MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer

Abstract

Similar works

Full text

Available Versions

Springer - Publisher Connector